Invst LLC Buys New Holdings in CME Group Inc. $CME

Invst LLC bought a new stake in CME Group Inc. (NASDAQ:CME) during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor bought 3,079 shares of the financial services provider’s stock, valued at approximately $817,000.

A number of other large investors have also recently bought and sold shares of CME. Wayfinding Financial LLC purchased a new stake in CME Group in the first quarter valued at approximately $25,000. Cornerstone Planning Group LLC boosted its position in CME Group by 122.2% in the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 55 shares in the last quarter. Golden State Wealth Management LLC boosted its position in CME Group by 612.5% in the 1st quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider’s stock worth $30,000 after purchasing an additional 98 shares in the last quarter. Ransom Advisory Ltd purchased a new stake in CME Group in the 1st quarter worth approximately $31,000. Finally, Alpine Bank Wealth Management purchased a new stake in CME Group in the 1st quarter worth approximately $32,000. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Insider Buying and Selling at CME Group

In other news, Director William R. Shepard acquired 256 shares of CME Group stock in a transaction that occurred on Wednesday, June 25th. The stock was purchased at an average cost of $270.53 per share, with a total value of $69,255.68. Following the purchase, the director owned 258,196 shares in the company, valued at $69,849,763.88. This trade represents a 0.10% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Sunil Cutinho sold 11,896 shares of the stock in a transaction on Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total value of $3,229,407.12. Following the completion of the transaction, the insider directly owned 17,440 shares of the company’s stock, valued at approximately $4,734,436.80. This represents a 40.55% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.30% of the stock is currently owned by corporate insiders.

CME Group Trading Down 0.0%

Shares of NASDAQ:CME opened at $262.30 on Friday. CME Group Inc. has a 1 year low of $212.38 and a 1 year high of $290.79. The firm has a market capitalization of $94.53 billion, a price-to-earnings ratio of 25.39, a price-to-earnings-growth ratio of 4.75 and a beta of 0.43. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. The business’s 50 day moving average price is $273.60 and its 200-day moving average price is $270.29.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.91 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The firm had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same quarter last year, the firm posted $2.56 EPS. The business’s revenue was up 10.4% on a year-over-year basis. On average, equities research analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Investors of record on Tuesday, September 9th will be paid a $1.25 dividend. This represents a $5.00 annualized dividend and a yield of 1.9%. The ex-dividend date of this dividend is Tuesday, September 9th. CME Group’s dividend payout ratio is currently 48.40%.

Wall Street Analysts Forecast Growth

Several research firms have commented on CME. Wall Street Zen lowered CME Group from a “hold” rating to a “sell” rating in a research report on Sunday, July 13th. Citigroup upped their price objective on CME Group from $265.00 to $275.00 and gave the stock a “neutral” rating in a research report on Thursday, July 3rd. Oppenheimer upped their price objective on CME Group from $300.00 to $303.00 and gave the stock an “outperform” rating in a research report on Thursday, July 24th. Piper Sandler upped their price objective on CME Group from $283.00 to $296.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 15th. Finally, Erste Group Bank lowered CME Group from a “strong-buy” rating to a “hold” rating in a research report on Saturday, May 24th. Four analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, CME Group has a consensus rating of “Hold” and an average price target of $260.60.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.